ArticleCancers2022

Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases.

Valentina Giannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.